Search clinical trials for: chidamide and azacitidine
Total 271427 results
-
Uma BorateSumitomo Pharma Oncology, Inc.CompletedAcute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Therapy-Related Acute Myeloid LeukemiaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Lung Non-Small Cell Carcinoma | Stage IV Lung Non-Small Cell Cancer AJCC v7United States
-
The First Affiliated Hospital of Zhengzhou UniversityNot yet recruitingEsophageal Squamous Cell Carcinoma
-
Peking Union Medical College HospitalPeking University Third Hospital; Dongzhimen Hospital, Beijing; Beijing Longfu...RecruitingCutaneous T-cell LymphomaChina
-
Sun Yat-sen UniversityRecruitingRelapsed or Refractory B-cell Non-Hodgkin's Lymphoma (NHL)China
-
Guangdong Provincial People's HospitalUnknown
-
Washington University School of MedicineNational Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | Leukemia, Myeloid, AcuteUnited States
-
The First Affiliated Hospital of Soochow UniversityRecruiting
-
The Hospital for Sick ChildrenCompletedChildhood Solid Tumor | Recurrent Childhood CNS Tumor | Ependymoma, Recurrent ChildhoodUnited States, Canada, Australia
-
The University of Texas Health Science Center,...CompletedBrain Tumor RecurrentUnited States
-
Beijing 302 HospitalNot yet recruitingHR+/HER2- Advanced Breast CancerChina
-
Shandong UniversityUnknownThrombocytopeniaChina
-
SymBio PharmaceuticalsWithdrawnMyelodysplastic SyndromeJapan
-
National Cancer Institute (NCI)CompletedRecurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Leukemia Cutis | Acute Myeloid Leukemia With t(9;11)(p21.3;q23.3); MLLT3-MLLUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedAcute Myeloid Leukemia | Myelodysplastic Syndrome | Myeloproliferative Neoplasm | Myelodysplastic/Myeloproliferative NeoplasmUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingPrimary Myelofibrosis | Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable | Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase | Myelofibrosis Transformation in Essential ThrombocythemiaUnited States
-
Brenda Cooper, MDNational Cancer Institute (NCI)CompletedUntreated Adult Acute Myeloid LeukemiaUnited States
-
Chipscreen Biosciences, Ltd.RecruitingNon Small Cell Lung CancerChina
-
Tianjin Medical University Cancer Institute and...RecruitingAdvanced HER2 Negative Breast Carcinoma | HRD+Breast CancerChina
-
Tianjin Medical University Cancer Institute and...UnknownTriple-negative Breast CancerChina
-
Chinese PLA General HospitalThe General Hospital of Western Theater Command; First Hospital of China Medical... and other collaboratorsRecruitingAcute Myeloid LeukemiaChina
-
Sun Yat-sen UniversityRecruitingBladder Cancer Stage IVChina
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Celgene CorporationCompletedSolid Tumors | Virally Mediated Cancers and LiposarcomaUnited States
-
Shenzhen Second People's HospitalRecruitingAcute Myeloid Leukaemia; Myelodysplastic Syndromes;Chronic Myelomonocytic LeukemiaChina
-
Sun Yat-sen UniversityRecruitingCervical Cancer | Cervix Cancer | Cervix NeoplasmChina
-
M.D. Anderson Cancer CenterRecruitingMyelodysplastic Syndrome | Recurrent Chronic Myelomonocytic Leukemia | Recurrent Myelodysplastic Syndrome | Chronic Myelomonocytic Leukemia-1 | Chronic Myelomonocytic Leukemia-2 | Chronic Myelomonocytic Leukemia-0United States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMyelodysplastic Syndrome | High Risk Myelodysplastic Syndrome | IPSS Risk Category Intermediate-1United States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)CompletedAcute Myeloid Leukemia | Myelodysplastic SyndromeUnited States
-
M.D. Anderson Cancer CenterTerminatedLeukemiaUnited States
-
The First Affiliated Hospital of Xiamen UniversityThe First Affiliated Hospital with Nanjing Medical University; Shanxi Province... and other collaboratorsRecruitingFollicular Lymphoma | Relapsed Non-Hodgkin Lymphoma | Refractory B-Cell LymphomaChina
-
Great Novel Therapeutics Biotech & Medicals CorporationRecruitingRelapsed or Refractory Peripheral T-cell LymphomaTaiwan
-
HUYABIO International, LLC.CompletedNon-Hodgkin's LymphomaJapan
-
University of OklahomaCelgene CorporationTerminatedPancreatic CancerUnited States
-
Beijing 302 HospitalRecruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Genentech, Inc.RecruitingAcute Myeloid Leukemia | Therapy-Related Acute Myeloid Leukemia | Hematologic and Lymphocytic Disorder | Acute Myeloid Leukemia in Remission | FLT3 Gene Mutation | Minimal Residual Disease PersistenceUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)WithdrawnStage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Genentech, Inc.RecruitingRecurrent Chronic Myelomonocytic Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Chronic Myelomonocytic Leukemia | Refractory Myelodysplastic Syndrome | Therapy-Related Myelodysplastic SyndromeUnited States
-
M.D. Anderson Cancer CenterRecruitingAcute Myeloid Leukemia | Therapy-Related Acute Myeloid Leukemia | Acute Bilineal Leukemia | Acute Biphenotypic Leukemia | T Acute Lymphoblastic Leukemia | Mixed Phenotype Acute LeukemiaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); CelgeneRecruitingAcute Myeloid Leukemia | Chronic Myelomonocytic Leukemia | Myelodysplastic Syndrome With Excess Blasts | IDH2 Gene Mutation | Recurrent High Risk Myelodysplastic Syndrome | Refractory High Risk Myelodysplastic Syndrome | Blasts 20-30 Percent of Bone Marrow Nucleated CellsUnited States
-
National Cancer Institute (NCI)WithdrawnRecurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia
-
The First Affiliated Hospital of Xiamen UniversityThe First Affiliated Hospital with Nanjing Medical University; Shanxi Province... and other collaboratorsRecruitingPeripheral T Cell Lymphoma | Relapsed Peripheral T-Cell Lymphoma | Refractory T-Cell LymphomaChina
-
The First Affiliated Hospital of Soochow UniversityRecruitingAcute Myeloid Leukemia (Relapsed/Refractory)China
-
Peking University Cancer Hospital & InstituteRecruiting
-
Ascentage Pharma Group Inc.Recruiting
-
Chipscreen Biosciences, Ltd.Active, not recruitingNon Small Cell Lung CancerChina
-
Sun Yat-sen UniversityRecruitingPeripheral T-Cell Lymphoma With Follicular Helper of T Cell PhenotypeChina
-
Peking Union Medical College HospitalRecruitingPeripheral T Cell LymphomaChina
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingChronic Myelomonocytic Leukemia | Myelodysplastic Syndrome | Recurrent Myelodysplastic Syndrome | Refractory Myelodysplastic Syndrome | Therapy-Related Myelodysplastic SyndromeUnited States
-
M.D. Anderson Cancer CenterCelgene CorporationCompletedLeukemiaUnited States
-
Carlos Graux, MD, PhDCelgene Corporation; Belgian Hematological SocietyCompletedMyelodysplastic Syndrome | Acute Myelogenous LeukemiaBelgium